ITCC-085 Aurora Kinase A
A Phase 1 Study of Aurora Kinase A Inhibitor LY3295668 Erbumine as a Single Agent and in Combination in Patients With Relapsed/Refractory Neuroblastoma
Promotor Name : Eli Lilly
Investigator Name :
Trial registered on clinicaltrial.gov: NCT04106219
